Clinical Strength MiracleDry Antiperspirant Deodorant PM

Manufacturer: Highland Consumer Products | Englewood Lab, Inc.
Effective date: 2023-12-12
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 00:04:09

Label at a glance#

ProductClinical Strength MiracleDry Antiperspirant Deodorant PM

Active ingredientALUMINUM CHLORIDE

Label structure10 sections

Indications and uses

Treats excessive perspiration and reduces underarm wetness and odor.

Dosage and administration

Apply to underarms only. Use every other night or as needed (e.g. every night or every 3rd nights). Apply only at bedtime. Apply few strokes to underarms after tipping bottle to get maximum effect.

Storage and handling

Keep at room temperature

Contacts and useful links#

Websitewww.miracledry.com

www.miracledry.com

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Aluminum Chloride Hexahydrate 12%

OTC - PURPOSE SECTION

Antiperspirant

Uses

INDICATIONS & USAGE SECTION

Treats excessive perspiration and reduces underarm wetness and odor.

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on irritated skin.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away

Stop use and contact a doctor

OTC - STOP USE SECTION

if rash or irritation develops

Ask your doctor

OTC - ASK DOCTOR SECTION

before using if you have kidney disease

Directions

DOSAGE & ADMINISTRATION SECTION

Apply to underarms only. Use every other night or as needed (e.g. every night or every 3rd nights). Apply only at bedtime. Apply few strokes to underarms after tipping bottle to get maximum effect.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water, PPG-11 Stearyl Ether, Cyclopentasiloxane, Steareth-2, Glycine, Steareth-20, Zinc Oxide, Sodium Bicarbonate, Isopropyl Myristate, Steareth-21

Storage

STORAGE AND HANDLING SECTION

Keep at room temperature

Questions?

OTC - QUESTIONS SECTION

www.miracledry.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

clinical strength Miracle Dry ANTIPERSPIRANT DEODORANT PM NIGHT formula 1.2 FL OZ 35.5 ML

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Miracle Dry PM

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53897-001-01	Clinical Strength MiracleDry Antiperspirant Deodorant PM	35.5 mL in 1 BOTTLE	LIQUID	35.5		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53897-001	CLINICAL STRENGTH MIRACLEDRY ANTIPERSPIRANT DEODORANT PM (ALUMINUM CHLORIDE) LIQUID [HIGHLAND CONSUMER PRODUCTS]	8	Current NDC, Legacy NDC, 1 package rows	20231213_f8f12e81-517b-4297-a61d-2e6daec53496.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALUMINUM CHLORIDE	ACTIVE INGREDIENT	3CYT62D3GA	2
ALUMINUM CATION	ACTIVE MOIETY	3XHB1D032B	2
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	2
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	2
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	2
PPG-11 STEARYL ETHER	INACTIVE INGREDIENT	S4G2J0Y0LG	2
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	2
STEARETH-2	INACTIVE INGREDIENT	V56DFE46J5	2
STEARETH-20	INACTIVE INGREDIENT	L0Q8IK9E08	2
STEARETH-21	INACTIVE INGREDIENT	53J3F32P58	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2
ZINC OXIDE	INACTIVE INGREDIENT	SOI2LOH54Z	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Clinical Strength MiracleDry Antiperspirant Deodorant PM
ALUMINUM CHLORIDE
WATER
PPG-11 STEARYL ETHER
CYCLOMETHICONE 5
STEARETH-2
GLYCINE
STEARETH-20
ZINC OXIDE
SODIUM BICARBONATE
ISOPROPYL MYRISTATE
STEARETH-21
ALUMINUM CATION

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
53897-001	53897-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
PPG-11 STEARYL ETHER	S4G2J0Y0LG	IACT
CYCLOMETHICONE 5	0THT5PCI0R	IACT
STEARETH-2	V56DFE46J5	IACT
GLYCINE	TE7660XO1C	IACT
STEARETH-20	L0Q8IK9E08	IACT
ZINC OXIDE	SOI2LOH54Z	IACT
SODIUM BICARBONATE	8MDF5V39QO	IACT
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
STEARETH-21	53J3F32P58	IACT
ALUMINUM CHLORIDE	3CYT62D3GA	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 154 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 68 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 6 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 20 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 20 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, SOLUTION / INTRAVENOUS		52 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	CAPSULE / ORAL		320 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, EFFERVESCENT / ORAL		57600 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		3219 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-20	STEARETH-20	L0Q8IK9E08	CREAM / TOPICAL	4.15 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OIL / TOPICAL		213 mg	Exact identifier — unii+route 20 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	GEL / TOPICAL		29 mg	Exact identifier — unii+route 20 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRAMUSCULAR		175 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INSERT / VAGINAL		129 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, CHEWABLE / ORAL		267 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, ORALLY DISINTEGRATING / ORAL		60 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL / TOPICAL	2.5 %w/w		Exact identifier — unii+route 6 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, COATED / ORAL	10.6 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, FILM COATED / ORAL		86 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	LOZENGE / ORAL		100 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ZINC OXIDE	ZINC OXIDE	SOI2LOH54Z	LOTION / TOPICAL	16 %w/w		Exact identifier — unii+route 2 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRAMUSCULAR		175 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 68 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	LOTION / TOPICAL		50 mg	Exact identifier — unii+route 20 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	GUM, CHEWING / BUCCAL		240 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET / ORAL	1300 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	GUM, CHEWING / BUCCAL		240 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	GUM, CHEWING / ORAL		360 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION / INTRATHECAL	0.05 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION / INTRAMUSCULAR		68 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	LOTION / TOPICAL	0.4 %w/w		Exact identifier — unii+route 8 equally ranked IID candidates
PPG-11 STEARYL ETHER	POLYPROPYLENE GLYCOL 11 STEARYL ETHER	S4G2J0Y0LG	SUSPENSION / TOPICAL		2288 mg	Exact identifier — unii+route 4 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTABLE, LIPOSOMAL / INTRAVENOUS	0.38 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INSERT / VAGINAL		129 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET / BUCCAL		42 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, EXTENDED RELEASE / ORAL		81 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	FILM, SOLUBLE / ORAL		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	SOLUTION / RESPIRATORY (INHALATION)	2 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
STEARETH-2	STEARETH-2	V56DFE46J5	OINTMENT / TOPICAL		714 mg	Exact identifier — unii+route 8 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	LOZENGE / ORAL		100 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		3219 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET, CHEWABLE / ORAL	140 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET / ORAL	163.31 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	CREAM, AUGMENTED / TOPICAL		260 mg	Exact identifier — unii+route 6 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	40 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	CAPSULE / ORAL		320 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
CYCLOMETHICONE 5	CYCLOMETHICONE 5	0THT5PCI0R	AEROSOL, FOAM / TOPICAL		144 mg	Exact identifier — unii+route 6 equally ranked IID candidates
SODIUM BICARBONATE	SODIUM BICARBONATE	8MDF5V39QO	TABLET / ORAL	1300 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OIL / TOPICAL		213 mg	Exact identifier — unii+route 20 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	SPRAY / TOPICAL		3665 mg	Exact identifier — unii+route 20 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clinical Strength MiracleDry Antiperspirant Deodorant PM	ALUMINUM CHLORIDE	Highland Consumer Products	f8f12e81-517b-4297-a61d-2e6daec53496	2023-12-12	Warnings	Exact identifier ndc (package): 53897-001-01 ndc (product): 53897-001 ndc11 (package): 53897000101 spl id: 0c5b6a69-0a65-0f46-e063-6294a90a4fca spl set id: f8f12e81-517b-4297-a61d-2e6daec53496

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.